As of Mar 23
| -0.10 / -0.59%|
The 5 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 26.00 and a low estimate of 20.00. The median estimate represents a +42.43% increase from the last price of 16.85.
The current consensus among 5 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.